bf/NASDAQ:AKU_icon.jpeg

COM:AKUMIN

Akumin

  • Stock

USD

Last Close

0.35

25/10 20:00

Market Cap

26.27M

Beta: -

Volume Today

7.89M

Avg: -

Company Overview

Metric
Company NameAkumin Inc.University of Rochester Medical Center
SymbolAKU
MSH IDCOM:AKUMINEDU:ROCHESTER:URMC
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryMedical - Diagnostics & ResearchHealth Care
CountryUSUS
Stage
Employee Count1.74K
Websiteakumin.comurmc.rochester.edu
LinkedIn
Founders

Market Metrics

Metric
Market Cap26.27M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue749.63M
Revenue (LTM)
Revenue (NTM)
Gross Profit141.25M
EBITDA139.86M
Operating Income41.66M
Net Income-151.59M
EPS-1.69
Diluted EPS-1.69
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.18
Operating Profit Margin-0.04
EBITDA Margin0.19
Net Profit Margin-0.30
Return on Equity2.83
Return on Assets-0.14
Return on Capital Employed-0.02

Valuation Multiples

Metric
P/E Ratio-0.12
P/B Ratio-0.15
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio0.04
EV Multiple-11.15

Operational Metrics

Metric
Days Sales Outstanding56.83
Days Payables Outstanding25.96
Days Inventory Outstanding5.05
Operating Cycle19.06
Cash Conversion Cycle32.12
Asset Turnover0.45

Cash Flow Metrics

Metric
Operating Cash Flow65.37M
Free Cash Flow20.61M
Cash Flow to Debt0.04
Operating Cash Flow/Sales0.08
Free Cash Flow Yield0.82

Balance Sheet Metrics

Metric
Cash & Equivalents59.42M
Accounts Receivable14.33M
Inventory8.00M
Goodwill769.11M
Debt to Capitalization1.14
Debt to Assets0.91
Current Ratio0.99
Quick Ratio0.88

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.00
R&D to Revenue
SG&A to Revenue0.00